Newborn Screening Laboratory

Newborn screening (NBS) is a public health population based screening system designed to detect and treat infants with special needs who have certain hematologic, endocrine or metabolic disorders. The goal of newborn screening is to eliminate or reduce mortality, morbidity and disabilities that result from the disorders included in the screening panel through early detection and treatment. Early detection of these disorders can prevent the infant from having seizures, physical disabilities, mental retardation, chronic illness or death. By obtaining a few drops of blood from an infant's heel, tests are performed to help find the conditions so treatment can begin early and prevent these effects.

As of July 1, 2007, Louisiana is screening for all disorders recommended by the American College of Medical Genetics (ACMG). For more information on Newborn Screening, please click on the links below:

Acquiring Newborn Screening Results

Secure Remote Viewer (SRV) Electronic Lab Results Registration - September 27, 2018

Effective immediately, the OPH state laboratory will no longer send out physical copies of Newborn Screening lab results to providers. Medical providers will be able to view the Newborn Screening lab results through our Secured Remote Viewer Web Based System (SRV). Please fill out the registration form and fax it to 504-568-8253. Instructions on accessing SRV can be found here.


Due to updates in our policies to comply with regulatory requirements, all newborn screening specimens must have a Hospital ID/Medical Record/Clinic ID Number provided on the forms as the second unique patient identifier.

Beginning March 1, 2023 we will no longer call to obtain this information and we cannot add the information to the form. This practice would be considered relabeling of the specimen which is not allowed by laboratory regulations. If the second identifier is missing, the specimen will not be tested and will need to be recollected and resubmitted with the complete information included on the form.


***Effective 7 a.m. on June 14, 2022, the Secure Remote Viewer (SRV), used to retrieve newborn screening results, will only be accessible by Chrome, Firefox or Edge web browsers. Users are encouraged to download one of these browsers to access SRV since Internet Explorer will no longer support Windows 10.

If there are any issues accessing the system after this date, please contact the Genetic Diseases Program at 504-568-8254.***




***NOTICE: The Policy for Early Collection and Blood Transfusion Collection has changed. Please click here for more details

For more information, please contact the NBS lab at 225-219-5248.


Surgeon General Ralph L. Abraham, M.D.

Interim Secretary Drew Maranto

Powered by Cicero Government